Launch Excellence_Standards for Medical Affairs

Where Medical Affairs may have served in a scientific support role in years past, now it is one of the key drivers of all efforts, positioned at the nexus of Regulatory, Clinical, Market Access, and Commercial needs, as a bridge to all and as a strategic partner with Commercial. This has occurred in large part because the days of successfully launching a new product based solely on making it available through regulatory approval and marketing efforts no longer exists. Use the MAPS Launch Excellence Standards & Guidance plus templates to guide your launch planning process in this new Medical Affairs landscape.

Authors

Ramin Farhood, PharmD, MBA

Ramin Farhood, PharmD, MBA

Vice President, Head of Global Medical Affairs, AveXis
Greg Keenan, MD

Greg Keenan, MD

Former Vice President, Medical Affairs and US Head Medical Officer, AstraZeneca
Tricia L. Gooljarsingh, PhD, CMPP

Tricia L. Gooljarsingh, PhD, CMPP

Senior Director, Ironwood Pharmaceuticals
Meg Heim, RN, MAS

Meg Heim, RN, MAS

Vice President, Head of North America DCV Scientific Communications, NA DCV Medical Affairs, Sanofi
Lobna Salem, MD, MBA

Lobna Salem, MD, MBA

Chief Medical Officer, Developed Markets, Upjohn Pfizer
Paul Tebbey, PhD, MBA

Paul Tebbey, PhD, MBA

Therapeutic Area Head, US Oncology Medical Affairs, AbbVie
Anna Walz

Anna Walz

CEO and Founder, MedEvoke